Forbes Medi-Tech




Previous. All pages. Next. Page 1. Page 2

December 29, 2000  Forbes Medi-Tech Reports First Quarter 2001 Financial Results
December 20, 2000  Forbes Appoints Technology Advisory Board
December 18, 2000  Forbes Medi-Tech Inc. Reports Fourth Quarter and Year-end Results for the fiscal year ended July 31, 2000
December 13, 2000  Forbes Announces the Appointment of Joe Dunne to the Board of Directors
December 07, 2000  Forbes Provides Corporate Update
November 29, 2000  Forbes Develops "Designer Oil" Which Lowers Cholesterol And May Prevent Weight Gain
November 21, 2000  Forbes Opens $3 Million Biotechnology Research Laboratories On University Of British Columbia Campus
November 09, 2000  Forbes Appoints Senior Pharmaceutical Executive to Board of Directors
October 31, 2000  Forbes reports additional exciting data on FM-VP4 - a novel cardiovascular pharmaceutical compound
October 19, 2000  PHYTROL(tm) BASED FOOD PRODUCTS LAUNCHED IN AUSTRALIA AND THE USA
August 29, 2000  Forbes Provides Corporate Update
August 14, 2000  Forbes Signs Manufacturing, Sales and Marketing Agreements for Pharmaceutical Steroid Products
July 14, 2000  Forbes Medi-Tech Completes CDN $27.75 Million Financing
July 11, 2000  Forbes Medi-Tech Appoints CFO, Senior Vice President
July 05, 2000  Forbes Medi-Tech Announces CDN $18.5 Million Bought Deal
June 30, 2000  Forbes Medi-Tech Announces Equity Offering
June 28, 2000  Forbes Medi-Tech Signs Supply Agreement with Cargill and Reports Third Quarter Results
June 19, 2000  Forbes Granted Patent on Microbial Conversion of Phytosterols to Steroid Drug Intermediates
June 14, 2000  New Pharmaceutical Compound Dramatically Reduced Atherosclerotic Lesions in Pre-Clinical Trails
May 25, 2000  Preliminary Study Results Indicate Exceptional Cholesterol Lowering Capability of New Pharmaceutical Compound
May 24, 2000  Exercise of Forbes Warrants Results in Gross Proceeds of $6.6 Million
May 04, 2000  Phytrol(tm) Receives FDA Clearance
April 25, 2000  Forbes Medi-Tech Announces Management Changes
April 25, 2000  Forbes Medi-Tech Obtains BC Technology Award
April 04, 2000  Forbes Medi-Tech Initiates US Phase II Trial for CardioRexTM

Previous. All pages. Next. Page 1. Page 2